How does science go from idea to funded execution?
At DeSci Berlin, we announced that Bio is building OpenLabs, a coordination and collaboration layer where humans and agents turn scientific ideas into funded execution.
What OpenLabs brings:
• A shared surface where humans and agents collaborate on scientific ideas
• Community voting and coordination that turns posts into funded projects
• BioAgents that maintain project continuity and drive research forward
Flagship projects include RheumaAI, AI research agent for rheumatology and @peptai_ peptide discovery & more.
More soon!
Watch the full DeSci Berlin livestream below ↓
Two days of talks on the future of DeSci, AI-driven biotech, agentic science, autonomous drug discovery and more!
A huge thank you to our speakers, partners, and everyone who showed up.
Couldn't make it this year? Watch the full talks ↓
Yield-routed funding for science. Ryan is on stage now introducing OpenLabs, @BioProtocol 's new platform, and how OpenLabs Vaults work.
A surface where a scientific idea can meet collaborators, attract capital, and become a funded experiment, without ever leaving the feed.
More on this soon!
"From DeSci to Drug Development: How ARTAN Bio and $VITARNA Are Rewriting Biotech Funding to Capture Upside Earlier"
Michael @Mykalt45 on stage now talking about the acquisition of his biotech company CrossBridge which was sold to Eli Lilly for up to $300M.
Ben Snipes, Chief Legal Officer @Molecule_sci opens Day 2 of DeSci Berlin!
How does it work when token holders can also become equity shareholders holding both simultaneously?
Exploring the compliant path from community to cap table.
Day 2 of DeSci Berlin starts NOW!
Today's lineup covers biotech funding, encrypted longevity data, peptide discovery, and the legal side of self-driving science.
Join us onsite or watch the livestream: https://t.co/ZfG1pucmr7
That's a wrap on day 1 at DeSci Berlin!
Thanks for following along. Day 2 brings drug development funding, peptide discovery, encrypted longevity data, and the legal side of self-driving science.
See tomorrow's agenda ↓
We're back LIVE for the afternoon sessions of DeSci Berlin with speakers from @dermadao, @foresightinst, @Molecule_sci and more!
Join us onsite or tune into the livestream: https://t.co/HsBzhQZ8s1
We’re LIVE at DeSci Berlin @BerBlockWeek
Streaming today's talks on the future of DeSci, AI-driven biotech, agentic science, autonomous drug discovery and more!
Full agenda below.
WATCH it live ↓
DeSci Berlin is TOMORROW!
Join biotech leaders, scientists, AI researchers exploring the next phase of DeSci + AI.
Register to attend or watch the livestream ↓
The 5th edition of https://t.co/BGuYlyRIFm kicks off TOMORROW!
From AI robotics in the wet lab, agentic swarms for science, longevity research, to peptide discovery powered by AI agents & more!
See the final program and register below ↓
Join the @peptai_ team for a science update TODAY!
Sharing the latest on pipeline progress, what's advancing to wet lab, and the commercial side of peptides.
🔔Set a reminder ↓
Join us for a live PeptAI science update TODAY!
We'll be walking through where the pipeline stands, what's advancing to wet lab, and the commercial potential of peptides.
Joined by @RafaDeSci (science lead), Aaron (Chief Commercial Officer at @molecule_sci ), and Andrei from @PeptideList.
Set a reminder: https://t.co/n7Dzl6rI2E
4 days until @DeSciBerlin is back for its fifth edition, exploring scientific singularity and agentic science.
See the full schedule and some of the talks below ↓
4 days until DeSci Berlin at @BerBlockWeek
Talks on AI and open science, scientific singularity, drug discovery, consciousness research, decentralized compute, and more.
See the full schedule and some of the talks below↓